Tag del av senaste nytt fran ADA. Medpagetoday har tre journalister som skriver online. Se nedan headlines. Las dem i fulltextt pa nedan www eller klicka pa lank nederst

http://www.medpagetoday.com/MeetingCoverage/ADA/

Nyhetsinfo (SA)
www red DiabetologNytt


Orlando, FL • June 25 - 29, 2010

ADA: Antioxidants Won't Prevent Preeclampsia in Type 1 Diabetics
6/26/2010
Taking vitamins C and E during pregnancy won't reduce the risk of preeclampsia in women with type 1 diabetes, researchers say.

ADA: Weekly Diabetes Drug Holds Up to Popular Daily Agents
6/26/2010
ORLANDO -- A novel once-weekly formulation of exenatide (Bydureon) improves glucose control in type 2 diabetes compared with other antidiabetic agents that require daily dosing, according to results of two trials.


ADA: Diabetes Responsible for 10% of Vascular Deaths
6/25/2010
Nearly one in 10 heart disease deaths may be attributable to diabetes, researchers say.

ADA: New Inhaled Insulin Matches Injections for Type 2 Diabetes
6/24/2010
ORLANDO -- A novel formulation of inhaled insulin (Technosphere), when given at meals with bedtime insulin glargine (Lantus), equals twice-daily premixed biaspart insulin (NovoLog) for glucose control in type 2 diabetes, a randomized trial showed.

ADA: Novel Drug Promising as Metformin Add-on
6/24/2010
ORLANDO -- Adding dapagliflozin, an investigational selective sodium-glucose cotransporter-2 (SGLT2) inhibitor, to metformin may improve glycemic control in diabetic patients who aren't responsive to metformin monotherapy.